.Analysis of Debt
Difficulty: Advanced
Total Debt (Carrying Amount)
Abbott Laboratories, Statement of Financial Position, Debt
USD $ in millions
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| | Short-term borrowings | |||||
| | Current portion of long-term debt | |||||
| | Long-term debt, excluding current portion | |||||
| | Total debt (carrying amount) |
Source: Based on data from Abbott Laboratories, Annual Reports
| Item | Description | The company |
|---|---|---|
| Total debt (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Abbott Laboratories's total debt increased from 2015 to 2016 and from 2016 to 2017. |
Total Debt (Fair Value)
| Dec 31, 2017 | |
|---|---|
| Selected Financial Data (USD $ in millions) | |
| Short-term borrowings | |
| Long-term debt, including current maturities | |
| Total debt (fair value) | |
| Ratio | |
| Debt, fair value to carrying amount | |
Source: Based on data from Abbott Laboratories, Annual Reports
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt: %
| Interest Rate | Debt Amount1 | Interest Rate × Debt Amount | Weighted-average Interest Rate2 | |
|---|---|---|---|---|
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| Total | % |
Source: Based on data from Abbott Laboratories, Annual Reports
1 USD $ in millions
2 Weighted-average interest rate = 100 × ÷ = %
